Patterns of Immunogenicity of an Inactivated Hepatitis A Vaccine in Anti-HIV Positive and Negative Hemophilic Patients

Summary

Hepatitis A vaccination has been recommended to patients with hemophilia since they are exposed to potentially infectious clotting factor concentrates. Aim of this study was to assess the immunogenicity of vaccination in hemophiliacs, infected or not with the human immunodeficiency virus (HIV). A formalin-inactivated hepatitis A vaccine was injected subcutaneously to 113 susceptible adults and children and repeated after 1 and 6 months. 47 vaccinees were anti-HIV positive (28 asymptomatic, 15 with CD4 cell counts of less than 200/pl and 4 with symptomatic disease). The first dose of vaccine induced seroconversion, with antibody titers of at least 20 mlU/ml, in 89% of the 66 anti-HIV negative patients, 100% of them responding after the second injection. In anti-HIV positive hemophiliacs seroconversion rates and antibody titers were significantly lower than in non-infected patients. After 12 months, only 76% of anti-HIV positive vaccinees and 40% of those with signs of HIV disease progression maintained the antibody, whereas all anti-HIV negative patients had titers of 20 mlU/ml or more. Our results indicate that there is an association between defective response to hepatitis A vaccine and stage of progression of HIV disease.

• References

• 1 Mannucci PM. Outbreak of hepatitis A among Italian patients with hemophilia. Lancet 1992; 339: 819
• 2 Gerritzen A, Schneweis KE, Brackmann HH, Oldenburg J, Hanfland P, Gerlich WH, Caspari G. Acute hepatitis A in hemophiliacs. Lancet 1992; 340: 1231-1232
• 2 Temperley IJ, Cotter KP, Walsh TJ, Power J, Hillary IB. Clotting factors and hepatitis A. Lancet 1992; 340: 1466
• 4 Peerlinck K, Vermylen J. Acute hepatitis A in patients with hemophilia A. Lancet 1993; 341: 179
• 5 Horowitz B, Wiebe M, Lippin A, Strycker MH. Inactivation of viruses in labile blood derivates. Disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations. Transfusion 1985; 25: 516-522
• 6 Mannucci PM, Gdovin S, Gringeri A, Colombo M, Mele A, Schinaia N, Ciavarella N, Emerson SU, Purcell RH. Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. Ann Intern Med 1994; 119: 1-7
• 7 Tilzey AT, Palmer SJ, Barrow S, Perry KR, Tyrrell H, Safary A, Banatvala JE. Clinical trial with inactivated hepatitis A vaccine and recommendations for its use. Br Med J 1992; 304: 1272-1276
• 8 Davidson M, Krugman S, Sandman LA. Inactivated hepatitis A vaccine: a safety and immunogenicity study in health professionals. Vaccine 1992; 10 (Suppl. 01) 119-120
• 9 Papaevangelou G, Totos GR, Roumeliotou A, Safary A, Hepatitis A. vaccination in Greek military recruits. J Med Virol 1993; 40: 1-4
• 10 Zanetti AR, Mannucci PM, Tanzi E, Moroni GA, De Paschale M, Morfini M, Carnelli V, Tirindelli MC, De Biasi R, Ciavarella N, De Rosa V, Rodeghiero F, Colombo M. Hepatitis B vaccination of 113 hemophiliacs: lower antibody response in anti-LAV/HTLV-III-positive patients. Am J Hematol 1986; 23: 339-345
• 11 Mannucci PM, Zanetti AR, Gringeri A, Tanzi E, Morfini M, Messori A, Tirindelli MC, De Biasi R, Ciavarella N, Colombo M. Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV seropositive and HIV seronegative hemophiliacs. Arch Intern Med 1989; 149: 1333-1337
• 12 Andre FE, Hepburn A, D’Hondt E. Inactivated candidate vaccines for hepatitis A. In: Progress in Medical Virology Melnick JL. (ed) Basel; Karger: 1990. 37 72-95
• 13 Hadler SC. Hepatitis B prevention and human immunodeficiency virus (HIV) infection. Ann Intern Med 1988; 109: 92-94
• 14 Rumi MG, Colombo M, Romeo R, Boschini A, Zanetti AR, Gringeri A, Mannucci PM. Suboptimal response to hepatitis B vaccine in drug users. Arch Intern Med 1991; 151: 574-578
• 15 Mueller R, Chriske H, Deinhardt F, Jilg J, Theilmann L, Hess C, Hofmann F, Hopf U, Stickl H, Maiwald H, Bienzle U, Scoefeld C, Zimmermann H, Dietrich M, May B, Bock HL, Clemens R, Bogaerts H. Hepatitis A vaccination: schedule for accelerated immunization. Vaccine 1992; 10 (Suppl. 01) 124-125
• 16 Jilg W, Bittner R, Bock HL, Clemens R, Schaetzl H, Schmidt M, Andre FE, Deinhardt F. Vaccination against hepatitis A: comparison of different shortterm immunization schedules. Vaccine 1992; 10 (Suppl. 01) 126-128